The final, formatted version of the article will be published soon.
ORIGINAL RESEARCH article
Front. Microbiol.
Sec. Antimicrobials, Resistance and Chemotherapy
Volume 16 - 2025 |
doi: 10.3389/fmicb.2025.1526882
Identification of CMY-190, a novel chromosomally encoded AmpC β-lactamase, and plasmid-encoded KPC-2 in a clinical isolate of Citrobacter youngae
Provisionally accepted- 1 Institute of Antibiotics, Huashan Hospital, Fudan University, Shanghai, Shanghai Municipality, China
- 2 Department of Clinical Laboratory, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China
- 3 Key Laboratory of Clinical Pharmacology of Antibiotics, Ministry of Health, Shanghai, China
This study aims to investigates the antibiotic resistance phenotype and genotype of Citrobacter youngae strain YS01, isolated from a peritoneal effusion sample, focusing on both chromosomale and plasmid-mediated resistance mechanisms to inform clinical antibiotic therapy. Our resultsfindings reveal the presence of the chromosomally encoded β-lactamase CMY-190 and the plasmid encoded carbapenemase KPC-2, which confer resistance to cephalosporins and carbapenems, respectively. CMY-190 exhibits substrate and inhibition profiles similar to AmpC β-lactamases and , sharesing 88.05% amino acid identity with the plasmid-encoded enzyme CFE-2 from Citrobacter freundii pJA99. DNA sequence analysis identified the ampR gene upstream of both blaCMY-190 and blaKPC-2. In additionFurthermore, genes were identified surrounding the ampR-ampC region in C. youngae, including ORF1, the fumarate operon (frdABCD), blc, and lolB, were identified, a DNA fragment not present in other Citrobacter species. The ampR-ampC gene was cloned into the PHSG398 vector and expressed in Escherichia coli DH5α, with the transformed strain showing partial resistance to cephalosporins. The blaKPC-2 was carried by Tn1721, previously identified mainlyprimarily in Asian strains of Klebsiella pneumoniae strains. The eExpression of KPC-2 was confirmed by conjugation of the donor bacterium C. youngae with E. coli J53, and by transformation of the plasmid containing the blaKPC-2 into E. coli DH5α, with all the transformed strains demonstrating resistancet to carbapenems and elevated carbapenem MICs. To our knowledge, this is the first report of a novel chromosomally encoded AmpC β-lactamase gene, blaCMY-190, and the emergence of blaKPC-2 in C. youngae.
Keywords: Citrobacter youngae, blaCMY-190, AmpC β-lactamase, blaKPC-2, carbapenemase-producing Enterobacterales
Received: 12 Nov 2024; Accepted: 28 Jan 2025.
Copyright: © 2025 Liu, Shen, Zhang, Lei, Tang, WU, Lei, Yin, Zhang, Guo, Geng and Hu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Yan Geng, Department of Clinical Laboratory, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China
Fupin Hu, Institute of Antibiotics, Huashan Hospital, Fudan University, Shanghai, Shanghai Municipality, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.